Operating Rooms

A 50% Reduction In HAIs Produces Substantial Financial Rewards

Today most of us work in an OR that is protected by the most efficient HEPA and laminar flow systems; but it still happens. Viruses, VOCs and even bacteria get in. HEPA filtration is effective down to 0.3 microns. Viruses are considerably smaller than that. Unlike HEPA, an Airocide® bioconversion system is not size dependent and it eliminates anything organic to a 99.999% level on the very first pass.

This is significant considering the fact that The Journal of Bone and Joint Surgery is reporting that an estimated 30% of surgical site infections are directly deposited from the air. Orthopedics, otolaryngology--head and neck surgery, open heart and transplant surgery, are all at magnified risks of post-operative nosocomial infection.

MRSA is a major contributor to that 30% of surgical site infections and, despite opinions to the contrary, MRSA does become airborne.

In a 2001 study, Japanese doctors determined that MRSA could be found in hospital air. 20% of the MRSA particles were within the respirable range, of less than 4 µm. (Nb., Airocide technology, the patented NASA bioconversion technology, eliminates 99.999% of all airborne microbes including MRSA, without the use of Ozone or untethered free radicals). And unlike filter trapping solutions, Airocide is not size dependent. Employing a high k-factor hybrid TiO2 nanotechnology, an Airocide system is the best defense against the pathogens that somehow enter the OR despite the best barriers. Converting them into inert harmless trace vapors by molecular conversion.

Even though top hospitals tout post-op infection rates of only 1%, cutting them in half still produces dramatic improvements in net revenues. Do the math and you’ll see that by adding Airocide to the equation, cutting your surgical sites’ infection rates in half is very doable.

CASE STUDY: Reducing Airborne Microbes in the Surgical Operating Theater & Other Clinical Settings: A Study Utilizing the airocide System.

A team of MDs conducted a study at Texas A&M University to better understand how the airocide bioconversion system, could lower the occurrence of nosocomial infections in a variety of clinical settings. Airborne microbes were reduced by an average of 62.8% (68.7% in ENT Day Surgery, 25.0% in the Surgical Operating Room (OR), and 94.7% in the Surgical Instrument Sterile Preparation Room). Empirical correlation of this research data suggests that a reduction in nosocomial infections would follow an exponential decrease in nosocomial rates. Click here for study details.